Astal Laboratories Stock Price Analysis and Quick Research Report. Is Astal Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Astal Laboratories. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Astal Laboratories has a PE ratio of 9.8969881744272 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Astal Laboratories has ROA of 17.8588% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Astal Laboratories has a Current ratio of 1.7048.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Astal Laboratories has a ROE of 32.1208%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Astal Laboratories has a Debt to Equity ratio of 0.4112 which means that the company has low proportion of debt in its capital.

• Sales growth: Astal Laboratories has reported revenue growth of 171.6163% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Astal Laboratories for the current financial year is 19.8910183556227%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Astal Laboratories is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Astal Laboratories is Rs 8.6592. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Astal Laboratories in Ticker for free. Also, one can get the intrinsic value of Astal Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Astal Laboratories FAQs

Q1. What is Astal Laboratories share price today?
Ans: The current share price of Astal Laboratories is Rs 85.7.

Q2. What is the market capitalisation of Astal Laboratories?
Ans: Astal Laboratories has a market capitalisation of Rs 92.2989 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Astal Laboratories?
Ans: The PE ratio of Astal Laboratories is 9.8969881744272 and the P/B ratio of Astal Laboratories is 2.42260799262758, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Astal Laboratories share?
Ans: The 52-week high share price of Astal Laboratories is Rs 131.7, and the 52-week low share price of Astal Laboratories is Rs 66.72.

Q5. Does Astal Laboratories pay dividends?
Ans: Currently, Astal Laboratories does not pay dividends. Dividend yield of Astal Laboratories is around 0%.

Q6. What are the face value and book value of Astal Laboratories shares?
Ans: The face value of Astal Laboratories shares is Rs 10, while the book value per share of Astal Laboratories is around Rs 35.3751. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Astal Laboratories?
Ans: Astal Laboratories has a total debt of Rs 13.2682 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Astal Laboratories?
Ans: The ROE of Astal Laboratories is 32.1208% and ROCE of Astal Laboratories is 34.7755%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Astal Laboratories a good buy for the long term?
Ans: The Astal Laboratories long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Astal Laboratories undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Astal Laboratories appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Astal Laboratories’s financials?
Ans: You can review Astal Laboratories’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.